Christopher P. Riley serves as Executive Vice President at Danaher Corporation, a global science and technology innovator, where he plays a pivotal role in driving the company's strategic growth and corporate development initiatives. With over two decades of experience in the life sciences and diagnostics sectors, Riley joined Danaher in 2005 as Vice President of Business Development. His early career included leadership positions at General Electric Healthcare, where he honed his expertise in commercial operations, mergers and acquisitions, and global market expansion, contributing to significant revenue growth in medical imaging and biotechnology divisions. Throughout his tenure at Danaher, Riley has held progressively senior roles, including President of the Diagnostics Platform and Group Executive for the Life Sciences segment. He spearheaded transformative acquisitions such as Beckman Coulter and Leica Microsystems, which expanded Danaher's portfolio and enhanced its position as a leader in precision medicine and diagnostics. Under his leadership, these businesses achieved double-digit growth rates, operational efficiencies, and innovations that accelerated product development pipelines, earning him recognition as a key architect of Danaher's renowned Danaher Business System. In his current role as Executive Vice President, Riley oversees Danaher's corporate development, strategy, and portfolio management functions, guiding investments that align with the company's focus on high-growth areas like biotechnology and environmental solutions. His strategic vision has been instrumental in navigating complex market dynamics, fostering a culture of continuous improvement, and delivering shareholder value through disciplined capital allocation and innovation-driven expansion.